Drug Interaction Study on Linaprazan Glurate Capsules
Status:
RECRUITING
Trial end date:
2026-02-26
Target enrollment:
Participant gender:
Summary
This study is a drug-drug interaction (DDI) investigation involving Linaprazan Glurate capsules and a combination of clarithromycin tablets, amoxicillin capsules, and bismuth potassium citrate capsules. The study plan is divided into two parts: one involving Hp-negative healthy subjects and the other involving Hp-positive subjects.